Chembio stockholders reminded to tender shares before 6:00 pm new york city time, on march 28, 2023

Medford, n.y., march 21, 2023 (globe newswire) -- chembio diagnostics, inc. (nasdaq: cemi), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by biosynex sa.

CEMI Ratings Summary

CEMI Quant Ranking